학술논문
WS12-6 Evaluating appropriate PROMs in CARE-CF-1 trial: Lynovex® (cysteamine) an oral adjunct to SOC interventions in cystic fibrosis infectious exacebations
Document Type
Abstract
Author
Source
In Journal of Cystic Fibrosis June 2019 18 Supplement 1:S23-S24
Subject
Language
ISSN
1569-1993